Searched for
DIRECTOR BIOCON
Intellectual curiosity & infectious optimism: Industry cheers Kunal Shah's new role as WhatsApp HeadIndia Inc. is celebrating Kunal Shah's appointment as WhatsApp head, hailing it as a milestone for Indian startup leadership. Industry lead...
Bajaj auto foundation commits ₹400 crore for women in engineering, unveils ₹1,500-crore skilling planIn a bold step towards gender equality in engineering, Bajaj Auto Foundation is initiating a robust scholarship program for women in core e...
Mahadev app: ED files new request to bring promoter to India from UAEIndia's Enforcement Directorate is pushing to bring Mahadev app promoter Saurabh Chandrakar back from the UAE. His attempt to remove an Int...
Insider trading: Supreme Court upholds SAT clearance to Biocon MDThe Supreme Court has backed a tribunal's decision, clearing Biocon's managing director, Shreehas P Tambe, of insider trading allegations f...
West Bengal's electronics factory push; Fed jitters hit TCSWest Bengal is exploring ways to expand electronics manufacturing under EMC 2.0. This and more in today's ETtech Top 5.
Delhiites can now hire private fire auditors for fire safety certificatesDelhi's fire safety clearance process is set to become faster with the introduction of a third-party fire audit system. This comes after a ...
"Punch in the stomach after 20 years": How a JPMorgan employee won $4 million after being fired over a $600 food platterA former JPMorgan broker, fired over a $642.50 deli bill for a Super Bowl party, has been awarded $4.25 million in damages. A FINRA panel r...
Nifty stuck in a range but small and midcaps are where real money is being made: Ashish ChaturmohtaIndian stock markets may appear stagnant, but opportunities exist in small and midcap stocks. JM Financial's Ashish Chaturmohta highlights ...
Biocon shifts focus to margins, capacity utilisation after expansion phaseBiocon is shifting its strategy to focus on capacity utilization, margin expansion, and improved returns after significant investments in g...
Biocon reports 63% YoY fall in Q4 profit, final dividend of Rs. 0.50 recommendedBiocon's fourth-quarter net profit saw a significant drop of 63 percent year-on-year. This decline was attributed to exceptional charges im...
Biocon Q4 Results: Net profit down 57% at Rs 198.6 croreBiocon Ltd reported a 56.8% drop in Q4 net profit to Rs 198.6 crore, impacted by an Rs 80.4 crore exceptional item. Despite this, consolida...
Biocon’s Kiran Mazumdar-Shaw chooses niece Claire Mazumdar as successor: ReportBiocon founder Kiran Mazumdar-Shaw has announced her successor. Niece Claire Mazumdar will lead the company. Claire Mazumdar is the founder...
Syngene shares zoom 17% even as firm’s Q4 net profit drops 19% YoY. What's driving the surge?Syngene shares surged despite a 19% YoY decline in Q4FY26 net profit to Rs 148 crore, as earnings rebounded sharply from Rs 15 crore in the...
Stocks in news: TCS, HDFC Bank, ITC Hotels, Hyundai India, Adani EnterprisesMarkets surged for the fourth consecutive session, buoyed by favorable geopolitical cues. Key stocks like TCS, HDFC Bank, ITC Hotels, Hyund...
Biocon names insider Shreehas Tambe as MD & CEO for 5 years as Siddharth Mittal steps downBiocon announced a leadership change. Siddharth Mittal will step down as Managing Director and Chief Executive Officer on March 31. He will...
Biocon Q4 Results: Profit declines 4% to Rs 283 crConsolidated revenue from operations in the fourth quarter stood at Rs 2,408.8 crore as against Rs 1,842.1 crore in the year-ago period, it...
Biocon Biologics appoints Peter Piot as independent directorPiot was the founding executive director of UNAIDS.
Biocon elevates Siddharth Mittal as CEO and joint MDMittal takes over from Arun Chandavarkar who retired as chief executive and joint MD of the company on November 30.
Biocon among most reputed biotech employers globally: SurveyBiocon Ltd today said it has earned the distinction of being the only Asian biopharma company to feature among the top biotechnology employ...
- Buy Biocon with a target of 288: Deepak Mohoni
Biocon Ltd is a ‘BUY’ call with a target of Rs 288 and a stop loss of Rs 271.